Because tumor-associated MΦ are suggested to be involved in tumor progression and/or aggressiveness, we investigated the distribution and density of CD68 (M1, pro-inflammatory) MΦ and CD163 (M2, anti-inflammatory) MΦ. This evidence concerns the gene CD163 and neoplasm.